APA (7th ed.) Citation

R, B., G, C., C, B., C, M., M, L., L, T., . . . Y, Z. (2010). Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: Results from a phase 2A, randomized, placebo-controlled clinical trial. Archives of dermatology, 146(4), 446. https://doi.org/10.1001/archdermatol.2010.34

Chicago Style (17th ed.) Citation

R, Bissonnette, Chen G, Bolduc C, Maari C, Lyle M, Tang L, Webster J, and Zhou Y. "Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results from a Phase 2A, Randomized, Placebo-controlled Clinical Trial." Archives of Dermatology 146, no. 4 (2010): 446. https://doi.org/10.1001/archdermatol.2010.34.

MLA (9th ed.) Citation

R, Bissonnette, et al. "Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results from a Phase 2A, Randomized, Placebo-controlled Clinical Trial." Archives of Dermatology, vol. 146, no. 4, 2010, p. 446, https://doi.org/10.1001/archdermatol.2010.34.